Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy

Graham M Poage; Zachary C Hartman; Powel H Brown

doi:10.4161/cc.25871

Revealing targeted therapeutic opportunities in triple-negative breast cancers: a new strategy

Cell Cycle. 2013 Sep 1;12(17):2705-6. doi: 10.4161/cc.25871. Epub 2013 Jul 30.

Authors

Graham M Poage¹, Zachary C Hartman, Powel H Brown

Affiliation

¹ Department of Clinical Cancer Prevention; The University of Texas MD Anderson Cancer Center; Houston, TX USA.

No abstract available

Keywords: EZH2; JAK/STAT; LPA; cytokine/chemokine; tandem inhibition; targeted therapy; transcriptional profiling; triple-negative breast cancer; tumor stem cell.

Publication types

Editorial
Comment

MeSH terms

Animals
Female
Humans
Interleukin-6 / biosynthesis*
Interleukin-8 / biosynthesis*
Triple Negative Breast Neoplasms / immunology*
Triple Negative Breast Neoplasms / pathology*

Substances

Interleukin-6
Interleukin-8